Scholar Rock to Present Phase 3 SAPPHIRE Trial Design at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022)
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 6 - Topic Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Topic Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Topic Group Today - Breaking & Trending Today
Pharnext: Findings on Symptoms Burden of Charcot-Marie-Tooth Disease Type 1A From the 'Real-World' Digital Lifestyle Study, CMT&Me, to be Presented at the ICNMD 2022
DJ Pharnext: Findings on Symptoms Burden of Charcot-Marie-Tooth Disease Type 1A From the 'Real-World' Digital Lifestyle Study, CMT&Me, to be Presented at the ICNMD 2022 Pharnext Pharnext: Findings
Source: finanznachrichten.de